HRTS ETF
Tema Heart & Health ETF
LLY is HRTS's largest holding at 11.20% of the fund as of Sep 14, 2026. HRTS is Tema Heart & Health ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 11.20% | 11.2% | 5,343 | $6.08M | Health Care | Pharmaceuticals |
| 2 | T | Thermo Fisherscientific Inc.Health Care · Life Sciences Tools | 5.22% | 16.4% | 4,616 | $2.83M | Health Care | Life Sciences Tools |
| Sector and industry · Pro | ||||||||
| 3 | U | Unitedhealth Group Inc | 5.08% | 21.5% | 7,195 | $2.76M | ||
| 4 | — | Novo Nordisk As | 4.68% | 26.2% | 58,624 | $2.54M | ||
| 5 | M | Merck & Company Inc | 4.33% | 30.5% | 16,233 | $2.35M | ||
| 6 | R | Roche Holding Ag (Adr) | 3.93% | 34.4% | 38,978 | $2.14M | ||
| 7 | J | Johnson & Johnson - | 3.91% | 38.3% | 7,966 | $2.12M | ||
| 8 | R | Revolution Medicines Inc | 3.76% | 42.1% | 9,951 | $2.04M | ||
| 9 | C | Cytokinetics Inc | 3.69% | 45.8% | 27,649 | $2.00M | ||
| 10 | B | Bridgebio Pharma Inc_None_0 | 3.33% | 49.1% | 25,007 | $1.81M | ||
| 11 | G | Gilead Sciences | 3.20% | 52.3% | 11,884 | $1.74M | ||
| 12 | — | AstraZeneca PLC | 3.01% | 55.3% | 9,969 | $1.64M | ||
| 13 | A | Abbott Laboratories | 2.96% | 58.3% | 15,601 | $1.61M | ||
| 14 | — | Nvaesrtex Pharmaceuticals Inc | 2.95% | 61.2% | 3,079 | $1.60M | ||
| 15 | D | Danaher Corp | 2.90% | 64.1% | 7,756 | $1.58M | ||
| 16 | N | Novartis Ag - | 2.62% | 66.8% | 10,200 | $1.42M | ||
| 17 | A | AbbVie Inc. | 2.45% | 69.2% | 5,088 | $1.33M | ||
| 18 | M | Medtronic Plc Ordinary Shares | 2.25% | 71.5% | 13,029 | $1.22M | ||
| 19 | I | Intuitive Surgical Inc. | 2.23% | 73.7% | 3,200 | $1.21M | ||
| 20 | B | Bristol-Myers Squibb Co. | 2.21% | 75.9% | 18,719 | $1.20M | ||
| 21 | M | Mckesson Corp. | 1.98% | 77.9% | 1,182 | $1.08M | ||
| 22 | D | Dexcom Inc. | 1.73% | 79.6% | 11,085 | $938.7K | ||
| 23 | M | Madrigal Pharmaceuticals Inc | 1.49% | 81.1% | 1,499 | $809.5K | ||
| 24 | — | Stryker Corp 3.375 11/25 | 1.42% | 82.5% | 2,733 | $770.4K | ||
| 25 | R | Regeneron Pharmaceuticals, Inc. | 1.36% | 83.9% | 929 | $737.4K | ||
| 26 | E | Edwards Lifesciences Corp | 1.35% | 85.2% | 8,572 | $733.1K | ||
| 27 | B | Boston Scientific Corp. | 1.26% | 86.5% | 15,214 | $685.4K | ||
| 28 | A | Alnylam Pharmaceuticals Inc. | 1.18% | 87.7% | 2,566 | $641.5K | ||
| 29 | — | Teva Pharmaceutical Industries Limited (Adr) | 1.18% | 88.9% | 16,554 | $641.0K | ||
| 30 | K | Kodiak Sciences Inc | 1.15% | 90.0% | 18,879 | $625.6K | ||
| 31 | C | Centene | 1.05% | 91.1% | 8,252 | $572.8K | ||
| 32 | — | Chugai Pharmaceutical Co. Ltd. Com Stk | 1.05% | 92.1% | 13,731 | $570.4K | ||
| 33 | — | Otsuka Holdings Co., Ltd. Com Stk | 0.98% | 93.1% | 7,300 | $532.6K | ||
| 34 | X | Xenon Pharmaceuticals Inc. Common Shares | 0.89% | 94.0% | 8,283 | $482.0K | ||
| 35 | A | Arrowhead Pharmaceuticals Inc | 0.78% | 94.8% | 5,263 | $424.6K | ||
| 36 | A | Amgen Inc. | 0.75% | 95.5% | 1,062 | $405.2K | ||
| 37 | F | First Am Treas Obli-X | 0.67% | 96.2% | 364,918 | $364.9K | ||
| 38 | S | Scholar Rock Holding Corp | 0.59% | 96.8% | 6,177 | $320.3K | ||
| 39 | M | Mbx Biosciences Inc | 0.55% | 97.3% | 5,010 | $298.0K | ||
| 40 | S | Stoke Therapeutics Inc | 0.54% | 97.9% | 9,917 | $293.5K | ||
| 41 | V | Viking Therapeutics Inc | 0.49% | 98.4% | 8,426 | $265.7K | ||
| 42 | I | Insmed Inc | 0.47% | 98.8% | 2,038 | $255.4K | ||
| 43 | P | Insulet Corp | 0.46% | 99.3% | 1,827 | $251.8K | ||
| 44 | Z | Zealand Pharma A/s | 0.41% | 99.7% | 5,223 | $224.8K | ||
| 45 | K | Kailera Therapeutics Inc | 0.36% | 100.1% | 14,039 | $193.0K | ||
| 46 | I | Ionis Pharmaceuticals Inc | 0.23% | 100.3% | 2,427 | $124.8K | ||
HRTS ETF All Holdings
HRTS holdings total 92 positions. The top 10 holdings account for 49.1% of the fund, led by Eli Lilly & Co. at 11.2%, Thermo Fisherscientific Inc. at 5.2%, Unitedhealth Group Incorporated at 5.1%.
HRTS portfolio concentration is moderate, with the top 10 representing 49.1% of total assets. The largest sector exposure is Health Care at 82.6%.
HRTS sectors provide a detailed breakdown. HRTS overlap shows how holdings compare to other funds in your portfolio.
HRTS ETF Holdings
46 of 92 holdings
- 1
Eli Lilly & Co.
LLYHealth Care11.20% - 2
Thermo Fisherscientific Inc.
TMOHealth Care5.22% - 3
Unitedhealth Group Incorporated
UNHHealth Care5.08% - 4
Novo Nordisk As
NOVO.B:COUnknown4.68% - 5
Merck & Company Inc
MRKHealth Care4.33% - 6
Roche Holding Ag (Adr)
RHHBY:SMUnknown3.93% - 7
Johnson & Johnson - Common
JNJHealth Care3.91% - 8
Revolution Medicines Inc
RVMDHealth Care3.76% - 9
Cytokinetics Inc
CYTKHealth Care3.69% - 10
Bridgebio Pharma Inc_None_0
BBIOHealth Care3.33% - 11
Gilead Sciences
GILDHealth Care3.20% - 12
AstraZeneca PLC
AZN:LNUnknown3.01% - 13
Abbott Laboratories
ABTHealth Care2.96% - 14
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care2.95% - 15
Danaher Corporation
DHRHealth Care2.90% - 16
Novartis Ag - Common
NOVN:SMUnknown2.62% - 17
Abbvie Inc.
ABBVHealth Care2.45% - 18
Medtronic Plc Ordinary Shares
MDTHealth Care2.25% - 19
Intuitive Surgical Inc.
ISRGHealth Care2.23% - 20
Bristol-Myers Squibb Co.
BMYHealth Care2.21% - 21
Mckesson Corp.
MCKHealth Care1.98% - 22
Dexcom Inc.
DXCMHealth Care1.73% - 23
Madrigal Pharmaceuticals Inc
MDGLHealth Care1.49% - 24
Stryker Corp 3.375 11/25
SYKHealth Care1.42% - 25
Regeneron Pharmaceuticals, Inc.
REGNHealth Care1.36% - 26
Edwards Lifesciences Corp
EWHealth Care1.35% - 27
Boston Scientific Corp.
BSXHealth Care1.26% - 28
Alnylam Pharmaceuticals Inc.
ALNYHealth Care1.18% - 29
Teva Pharmaceutical Industries Limited (Adr)
TEVA:ILHealth Care1.18% - 30
Kodiak Sciences Inc
KODHealth Care1.15% - 31
Centene
CNCHealth Care1.05% - 32
Chugai Pharmaceutical Co. Ltd. Com Stk
4519:JPUnknown1.05% - 33
Otsuka Holdings Co., Ltd. Com Stk
4578:JPUnknown0.98% - 34
Xenon Pharmaceuticals Inc. Common Shares
XENEHealth Care0.89% - 35
Arrowhead Pharmaceuticals Inc
ARWRHealth Care0.78% - 36
Amgen Inc.
AMGNHealth Care0.75% - 37
First Am Treas Obli-X
FXFXXFinancials0.67% - 38
Scholar Rock Holding Corporation Com
SRRKHealth Care0.59% - 39
Mbx Biosciences Inc
MBXHealth Care0.55% - 40
Stoke Therapeutics Inc Com
STOKHealth Care0.54% - 41
Viking Therapeutics Inc Com
VKTXHealth Care0.49% - 42
Insmed Inc
INSMHealth Care0.47% - 43
Insulet Corporation
PODDHealth Care0.46% - 44
Zealand Pharma A/s
ZEAL:COUnknown0.41% - 45
Kailera Therapeutics Inc
KLRAUnknown0.36% - 46
Ionis Pharmaceuticals Inc
IONSHealth Care0.23%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | LLY | 11.200% | ||
| 2 | Thermo Fisherscientific Inc. | TMO | 5.220% | ||
| 3 | Unitedhealth Group Incorporated | UNH | 5.080% | ||
| 4 | Novo Nordisk As | NOVO.B:CO | 4.680% | ||
| 5 | Merck & Company Inc | MRK | 4.330% | ||
| 6 | Roche Holding Ag (Adr) | RHHBY:SM | 3.930% | ||
| 7 | Johnson & Johnson - Common | JNJ | 3.910% | ||
| 8 | Revolution Medicines Inc | RVMD | 3.760% | ||
| 9 | Cytokinetics Inc | CYTK | 3.690% | ||
| 10 | Bridgebio Pharma Inc_None_0 | BBIO | 3.330% | ||
| 11 | Gilead Sciences | GILD | 3.200% | ||
| 12 | AstraZeneca PLC | AZN:LN | 3.010% | ||
| 13 | Abbott Laboratories | ABT | 2.960% | ||
| 14 | Nvaesrtex Pharmaceuticals Inc | VRTX | 2.950% | ||
| 15 | Danaher Corporation | DHR | 2.900% | ||
| 16 | Novartis Ag - Common | NOVN:SM | 2.620% | ||
| 17 | Abbvie Inc. | ABBV | 2.450% | ||
| 18 | Medtronic Plc Ordinary Shares | MDT | 2.250% | ||
| 19 | Intuitive Surgical Inc. | ISRG | 2.230% | ||
| 20 | Bristol-Myers Squibb Co. | BMY | 2.210% | ||
| 21 | Mckesson Corp. | MCK | 1.980% | ||
| 22 | Dexcom Inc. | DXCM | 1.730% | ||
| 23 | Madrigal Pharmaceuticals Inc | MDGL | 1.490% | ||
| 24 | Stryker Corp 3.375 11/25 | SYK | 1.420% | ||
| 25 | Regeneron Pharmaceuticals, Inc. | REGN | 1.360% | ||
| 26 | Edwards Lifesciences Corp | EW | 1.350% | ||
| 27 | Boston Scientific Corp. | BSX | 1.260% | ||
| 28 | Alnylam Pharmaceuticals Inc. | ALNY | 1.180% | ||
| 29 | Teva Pharmaceutical Industries Limited (Adr) | TEVA:IL | 1.180% | ||
| 30 | Kodiak Sciences Inc | KOD | 1.150% | ||
| 31 | Centene | CNC | 1.050% | ||
| 32 | Chugai Pharmaceutical Co. Ltd. Com Stk | 4519:JP | 1.050% | ||
| 33 | Otsuka Holdings Co., Ltd. Com Stk | 4578:JP | 0.980% | ||
| 34 | Xenon Pharmaceuticals Inc. Common Shares | XENE | 0.890% | ||
| 35 | Arrowhead Pharmaceuticals Inc | ARWR | 0.780% | ||
| 36 | Amgen Inc. | AMGN | 0.750% | ||
| 37 | First Am Treas Obli-X | FXFXX | 0.670% | ||
| 38 | Scholar Rock Holding Corporation Com | SRRK | 0.590% | ||
| 39 | Mbx Biosciences Inc | MBX | 0.550% | ||
| 40 | Stoke Therapeutics Inc Com | STOK | 0.540% | ||
| 41 | Viking Therapeutics Inc Com | VKTX | 0.490% | ||
| 42 | Insmed Inc | INSM | 0.470% | ||
| 43 | Insulet Corporation | PODD | 0.460% | ||
| 44 | Zealand Pharma A/s | ZEAL:CO | 0.410% | ||
| 45 | Kailera Therapeutics Inc | KLRA | 0.360% | ||
| 46 | Ionis Pharmaceuticals Inc | IONS | 0.230% |






































